Clinical implications of measurement of plasma atrial natriuretic peptide concentration in dogs with spontaneous heart disease

Journal of the American Veterinary Medical Association

Volumn 239, Issue 8, 2011, Pages 1077-1083

  Hori, Yasutomo ^a   Yamano, Shigeki ^b   Kanai, Kazutaka ^a   Hoshi, Fumio ^a   Itoh, Naoyuki ^a   Higuchi, Sei ichi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Kanie Animal Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DOG; DOG DISEASE; FEMALE; HEART DISEASE; MALE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DOG DISEASES; DOGS; FEMALE; HEART DISEASES; MALE;

ANIMALIA; CANIS FAMILIARIS;

EID: 80054038100     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.239.8.1077     Document Type: Article

References (24)

1. O'Sullivan ML, O'Grady MR, Minors SL. Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy. J Vet Intern Med 2007;21:92-99.
2. Oyama MA, Sisson DD, Solter PF. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res 2007;68:42-47.
3. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341-356.
4. Dzimiri N, Moorji A, Afrane B, et al. Differential regulation of atrial and brain natriuretic peptides and its implications for the management of left ventricular volume overload. Eur J Clin Invest 2002;32:563-569.
5. Borgeson DD, Stevens TL, Heublein DM, et al. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism. Clin Sci (Lond) 1998;95:195-202.
6. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-469.
7. Nagaya N, Nishikimi T, Uematsu M, et al. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 1998;136:297-301.
8. Maeda K, Tsutamoto T, Wada A, et al. Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction. J Appl Physiol 2000;89:458-464.
9. Hori Y, Tsubaki M, Katou A, et al. Evaluation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis. J Vet Intern Med 2008;22:1118-1123.
10. Greco DS, Biller B, Van Liew CH. Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease. Can Vet J 2003;44:293-297.
11. Gottlieb SS, Kukin ML, Ahern D, et al. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:1534-1539.
12. Grzybowski J, Bilinska ZT, Janas J, et al. Plasma concentrations of N-terminal atrial natriuretic peptide are raised in asymptomatic relatives of dilated cardiomyopathy patients with left ventricular enlargement. Heart 2002;88:191-192.
13. Katayama T, Nakashima H, Takagi C, et al. Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock. Circ J 2005;69:83-88.
14. Asano K, Masuda K, Okumura M, et al. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. J Vet Med Sci 1999;61:523-529.
15. Haggstrom J, Hansson K, Karlberg BE, et al. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels. Am J Vet Res 1994;55:698-703.
16. Buchanan JW, Bücheler J. Vertebral scale system to measure canine heart size in radiographs. J Am Vet Med Assoc 1995;206:194-199.
17. Hamlin RL. Analysis of the cardiac silhouette in dorsoventral radiographs from dogs with heart disease. J Am Vet Med Assoc 1968;153:1446-1460.
18. ISACHC. Recommendations for diagnosis of heart disease and treatment of heart failure in small animals. In: Fox PR, Sisson D, Moise NS, eds. Textbook of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders Co, 1999;883-901.
19. Biondo AW, Liu ZL, Wiedmeyer CE, et al. Genomic sequence and cardiac expression of atrial natriuretic peptide in cats. Am J Vet Res 2002;63:236-240.
20. Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-1515.
21. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-2397.
22. Berger R, Huelsmann M, Strecker K, et al. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. Eur J Clin Invest 2005;35:24-31.
23. Hori Y, Sano N, Kanai K, et al. Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs. Vet J 2009;185;317-321.
24. Boswood A, Dukes-McEwan J, Loureiro J, et al. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract 2008;49:26-32.